Cocrystal Pharma holds annual shareholder meeting

• On July 14, 2026, Cocrystal Pharma held its annual shareholder meeting.
• Shareholders selected five directors to serve until the next annual meeting.
• Weinberg & Company was ratified as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
• An adjournment authorization was not put into effect because support for the other items was sufficient.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cocrystal Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-033662), on July 17, 2026, and is solely responsible for the information contained therein.